A Disease Registry Encompassing The Care Of Patients With Multiple Myeloma On Panobinostat (RECOMM) Read more
A Phase 2, Multicohort Open-Label Study Of JNJ-68284528, A Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA In Subjects With Multiple Myeloma (CARTITUDE 2) Read more
A Phase 1/2, Multicenter, Dose-Escalation And Expansion Study Of Combination Therapy With Venetoclax, Daratumumab And Dexamethasone (With And Without Bortezomib) In Subjects With Relapsed Or Refractory Multiple Myeloma Read more
Clinical Grade Molecular Profiling Of Patients With Multiple Myeloma And Related Plasma Cell Malignancies Read more
A Phase 2B Study Of Selinexor (KPT-330), In Combination With Carfilzomib, Daratumumab Or Pomalidomide In Patients With Multiple Myeloma Relapsing On Current Therapy Read more
A Phase 1b/2 Study Of Selinexor (KPT-330) In Combination With Backbone Treatments For Relapsed/Refractory Multiple Myeloma Read more
Myeloma-Developing Regimens Using Genomics (Mydrug) (Genomics Guided Multi-Arm Trial Of Targeted Agents Alone Or In Combination With A Backbone Regimen) Read more
